-
公开(公告)号:US08263606B2
公开(公告)日:2012-09-11
申请号:US12578148
申请日:2009-10-13
申请人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
发明人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
IPC分类号: A61K31/44 , C07D213/02
CPC分类号: C07D513/22 , C07D491/10 , C07D491/107 , C07D491/20 , C07D491/22 , C07D495/20 , C07D498/20 , C07D513/20 , C07D519/00
摘要: This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
摘要翻译: 本发明涉及螺 - 羟吲哚化合物,作为立体异构体,对映体,其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。
-
2.
公开(公告)号:US20100137299A1
公开(公告)日:2010-06-03
申请号:US12578148
申请日:2009-10-13
申请人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
发明人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
IPC分类号: A61K31/5377 , C07D491/10 , C07D498/10 , C07D513/10 , A61K31/407 , A61K31/4439 , A61K31/429 , A61K31/424
CPC分类号: C07D513/22 , C07D491/10 , C07D491/107 , C07D491/20 , C07D491/22 , C07D495/20 , C07D498/20 , C07D513/20 , C07D519/00
摘要: This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
摘要翻译: 本发明涉及螺 - 羟吲哚化合物,作为立体异构体,对映体,其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。
-
3.
公开(公告)号:US20120295897A1
公开(公告)日:2012-11-22
申请号:US13557833
申请日:2012-07-25
申请人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
发明人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
IPC分类号: A61K31/407 , A61K31/429 , C07D491/20 , A61K31/4439 , A61K31/422 , C07D498/20 , A61K31/424 , A61K31/5383 , C07D491/107 , A61K31/475 , C07D495/20 , A61K31/4245 , A61K31/4985 , A61K31/4178 , A61K31/4155 , A61K31/5377 , A61K31/427 , A61K31/433 , A61K31/497 , A61K31/506 , A61K31/454 , A61K31/41 , A61K31/496 , A61P29/00 , A61P25/24 , A61P9/00 , A61P11/00 , A61P25/18 , A61P3/06 , A61P35/00 , A61P17/04 , C07D513/20
CPC分类号: C07D513/22 , C07D491/10 , C07D491/107 , C07D491/20 , C07D491/22 , C07D495/20 , C07D498/20 , C07D513/20 , C07D519/00
摘要: This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
摘要翻译: 本发明涉及螺 - 羟吲哚化合物,作为立体异构体,对映体,其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。
-
公开(公告)号:US08415370B2
公开(公告)日:2013-04-09
申请号:US13557833
申请日:2012-07-25
申请人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
发明人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
IPC分类号: A61K31/44 , C07D213/02
CPC分类号: C07D513/22 , C07D491/10 , C07D491/107 , C07D491/20 , C07D491/22 , C07D495/20 , C07D498/20 , C07D513/20 , C07D519/00
摘要: This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
摘要翻译: 本发明涉及螺 - 羟吲哚化合物,作为立体异构体,对映体,其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。
-
公开(公告)号:US20110269788A1
公开(公告)日:2011-11-03
申请号:US13142375
申请日:2009-12-29
申请人: Jean-Jacques Cadieux , Mikhail Chafeev , Sultan Chowdhury , Amy Frances Douglas , Jianmin Fu , Jonathan Langille , Shaoyi Sun , Mark Wood
发明人: Jean-Jacques Cadieux , Mikhail Chafeev , Sultan Chowdhury , Amy Frances Douglas , Jianmin Fu , Jonathan Langille , Shaoyi Sun , Mark Wood
IPC分类号: A61K31/4355 , A61K31/437 , A61P25/00 , A61P25/24 , A61P9/00 , A61P11/00 , A61P13/10 , A61P1/04 , A61P25/06 , A61P1/00 , A61P25/02 , A61P19/02 , A61P29/00 , A61P9/10 , A61P21/04 , A61P21/00 , A61P3/00 , A61P9/12 , A61P5/16 , A61P25/22 , A61P25/18 , A61P35/00 , A61P25/08 , A61P7/00 , A61P13/08 , A61P17/04 , C07D491/20
CPC分类号: C07D491/20 , C07D471/04
摘要: This invention is directed to spiro-oxindole compounds of formulas (I), (II), (III), as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
摘要翻译: 本发明涉及式(I),(II),(III)的螺 - 羟吲哚化合物,其立体异构体,对映异构体,互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。
-
-
-
-